All patients N = 104 | |
---|---|
Age (years) | |
Median (range) | 40 (18 - 89) |
Gender, n(%) | |
Male | 61 (58.7%) |
Female | 43 (41.3%) |
KPS (n = 71) | |
Median (Range) | 80 (20 - 100) |
≤ 70 | 26 (36.6%) |
> 70 | 45 (63.4%) |
Extend of resection | |
Stereotactical biopsy | 93 (89.4%) |
Microsurgical operation | 11 (10.6%) |
Histopathological WHO-diagnosis (n = 101) | |
Oligoastrocytoma II | 1 (1.0%) |
Anaplastic oligoastrocytoma III | 1 (1.0%) |
Ependymoma II | 2 (2.0%) |
Diffuse Astrocytoma II | 23 (22.8%) |
Anaplastic astrocytoma III | 39 (38.6%) |
Fibrillary astrocytoma | 4 (4.0%) |
Pilocytic astrocytoma | 17 (16.8%) |
Glioblastoma | 14 (13.9%) |
WHO grade (n = 103) | |
Low grade | 47 (45.6%) |
High grade | 56 (54.4%) |
First-line treatment (n = 101) | |
External beam radiation | 45 (44.6%) |
Radio-/Chemotherapy | 22 (21.8%) |
Interstitial radiosurgery | 7 (6.9%) |
Chemotherapy | 4 (4.0%) |
No tumor specific therapy | 23 (22.8%) |